111 related articles for article (PubMed ID: 1388643)
1. Intravenous cocaine challenges during desipramine maintenance.
Kosten T; Gawin FH; Silverman DG; Fleming J; Compton M; Jatlow P; Byck R
Neuropsychopharmacology; 1992 Nov; 7(3):169-76. PubMed ID: 1388643
[TBL] [Abstract][Full Text] [Related]
2. Effects of desipramine maintenance on cocaine self-administration by humans.
Fischman MW; Foltin RW; Nestadt G; Pearlson GD
J Pharmacol Exp Ther; 1990 May; 253(2):760-70. PubMed ID: 2338656
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.
Ziedonis D; Richardson T; Lee E; Petrakis I; Kosten T
Psychopharmacol Bull; 1992; 28(3):309-14. PubMed ID: 1480735
[TBL] [Abstract][Full Text] [Related]
4. Concurrent effects of acute intravenous cocaine in context of chronic desipramine in humans.
Pickett G; Kosten TR; Gawin FH; Byck R; Fleming J; Silverman D; Kosten TA; Jatlow P
NIDA Res Monogr; 1990; 105():508-9. PubMed ID: 1876102
[No Abstract] [Full Text] [Related]
5. Treating cocaine abusing methadone maintenance patients with desipramine.
Kosten T; Gawin F; Schumann B
NIDA Res Monogr; 1988; 81():237-41. PubMed ID: 3136366
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of cocaine in humans: laboratory studies.
Foltin RW; Fischman MW; Levin FR
Drug Alcohol Depend; 1995 Mar; 37(3):193-210. PubMed ID: 7796714
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and behavioral treatments of cocaine dependence: controlled studies.
O'Brien CP; Childress AR; Arndt IO; McLellan AT; Woody GE; Maany I
J Clin Psychiatry; 1988 Feb; 49 Suppl():17-22. PubMed ID: 3276670
[TBL] [Abstract][Full Text] [Related]
8. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.
Foltin RW; Christiansen I; Levin FR; Fischman MW
J Pharmacol Exp Ther; 1995 Oct; 275(1):38-47. PubMed ID: 7562574
[TBL] [Abstract][Full Text] [Related]
9. Continuity of care and desipramine in primary cocaine abusers.
Hall SM; Tunis S; Triffleman E; Banys P; Clark HW; Tusel D; Stewart P; Presti D
J Nerv Ment Dis; 1994 Oct; 182(10):570-5. PubMed ID: 7931205
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients.
Kosten TR; Schumann B; Wright D; Carney MK; Gawin FH
J Clin Psychiatry; 1987 Nov; 48(11):442-4. PubMed ID: 3680185
[TBL] [Abstract][Full Text] [Related]
11. Relapse to cocaine abuse after initiating desipramine treatment.
Weiss RD
JAMA; 1988 Nov; 260(17):2545-6. PubMed ID: 3172429
[TBL] [Abstract][Full Text] [Related]
12. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
Arndt IO; McLellan AT; Dorozynsky L; Woody GE; O'Brien CP
J Nerv Ment Dis; 1994 Mar; 182(3):151-6. PubMed ID: 8113775
[TBL] [Abstract][Full Text] [Related]
13. Predictive validity of the extinction/reinstatement model of drug craving.
Fuchs RA; Tran-Nguyen LT; Specio SE; Groff RS; Neisewander JL
Psychopharmacology (Berl); 1998 Jan; 135(2):151-60. PubMed ID: 9497020
[TBL] [Abstract][Full Text] [Related]
14. Depression as a prognostic factor for pharmacological treatment of cocaine dependence.
Ziedonis DM; Kosten TR
Psychopharmacol Bull; 1991; 27(3):337-43. PubMed ID: 1775608
[TBL] [Abstract][Full Text] [Related]
15. Desipramine facilitation of initial cocaine abstinence.
Gawin FH; Kleber HD; Byck R; Rounsaville BJ; Kosten TR; Jatlow PI; Morgan C
Arch Gen Psychiatry; 1989 Feb; 46(2):117-21. PubMed ID: 2492422
[TBL] [Abstract][Full Text] [Related]
16. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.
Kosten TR; Gawin FH; Morgan C; Nelson JC; Jatlow P
Am J Drug Alcohol Abuse; 1990; 16(3-4):329-36. PubMed ID: 2288330
[TBL] [Abstract][Full Text] [Related]
17. Research on desipramine in the treatment of cocaine abuse: a critique of Levin and Lehman's meta-analysis.
Delucchi KL
J Clin Psychopharmacol; 1992 Oct; 12(5):367-70. PubMed ID: 1479061
[No Abstract] [Full Text] [Related]
18. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
[TBL] [Abstract][Full Text] [Related]
19. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
Sobel BF; Sigmon SC; Griffiths RR
Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
[TBL] [Abstract][Full Text] [Related]
20. Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse.
Kosten TR
NIDA Res Monogr; 1993; 135():48-56. PubMed ID: 8289903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
